Melanoma

Evaluating PD-1 Inhibitors

Publish date: September 21, 2016

Researchers find positive safety and efficiency results for patients with malignant melanoma treated with PD-1 antibody monotherapy.

Author:: Brittany Dougall; James Gendreau; Sudarshana Das, CTR, Rhit; Craig Markham; Dana Capulong; Clayton LAU; Jordan Gemelas; Gregory J. Raugi, MD, PhD

Use of local SNOMED codes and clerical errors led to the underreporting of melanomas despite having an in-house reporting system and understanding...

Publish date: July 13, 2016

Publish date: March 3, 2015

Key clinical point: Patients with advanced melanoma and mutations in the NRAS gene had better responses to immunotherapy than did those without...